Nice, suspect good news, as they use the word "new" clinical data, if it was bad news you would just say update of clinical data, just my thoughts
The Company is requesting a trading halt pending the release of new clinical data from
the PARA_OA_008 Phase 2 clinical trial investigating iPPS in knee OA to the market
on Tuesday 10 October 2023.
Ann: Trading Halt, page-2
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 27.5¢ | 24.5¢ | $224.0K | 873.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 170003 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 36365 | 2 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
25.5¢ |
Change
0.000 ( 0.83 %) |
||||
| Open | High | Low | Volume | ||
| 25.5¢ | 27.5¢ | 24.5¢ | 141920 | ||
| Last updated 15.59pm 03/06/2024 ? | |||||
| PAR (ASX) Chart |